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Abstract
Background: Non-arthritic hip disorders are defined as abnormalities of the articulating surfaces of the acetabulum
and femur before the onset of osteoarthritis, including intra-articular structures such as the acetabular labrum and
chondral surfaces. Abnormal femoroacetabular morphology is commonly seen in young men who constitute much
of the UK military population. Residential multidisciplinary team (MDT) rehabilitation for patients with musculoskeletal
injuries has a long tradition in the UK military, however, there are no studies presenting empirical data on the efficacy
of a residential MDT approach compared with individualised conventional outpatient treatment. With no available data,
the sustainability of this care pathway has been questioned. The purpose of this randomised controlled trial is to
compare the effects of a residential multidisciplinary intervention, to usual outpatient care, on the clinical outcomes of
young active adults undergoing treatment for non-arthritic intra-articular hip pain.
Methods/design: The trial will be conducted at the Defence Medical Rehabilitation Centre, Headley Court, UK. One
hundred military male participants with clinical indicators of non-arthritic intra-articular hip pain will be randomly
allocated to either: (1) 7-day residential multidisciplinary team intervention, n = 50; (2) 6-week physiotherapist-led
outpatient intervention (conventional care), n = 50. Measurements will be taken at baseline, post-treatment (1-week
MDT group; 6-weeks physiotherapy group), and 12-weeks. The primary outcome measures are the function in daily
living sub-scale of the Copenhagen Hip and Groin Outcome Score (HAGOS), the physical function subscale of the
Non-arthritic Hip Score (NAHS), and VAS pain scale. Secondary outcomes include objective measures of physical
capacity and general health. An intention-to-treat analysis will be performed using linear and mixed models.
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Discussion: This study will be the first to assess the efficacy of intensive MDT rehabilitation, versus conventional
outpatient care, for the management of non-arthritic hip pain. The results from this study will add to the
evidence-base and inform clinical practice for the management of intra-articular non-arthritic hip pain and
femoroacetabular impingement in young active adults.
Trial registration: ISRCTN Reference: ISRCTN 59255714 dated 11-Nov-2015
Keywords: Non-arthritic hip pain, Femoroacetabular impingement, Multidisciplinary team, Residential rehabilitation,
Physiotherapy, Military personnel
Background
Hip and groin pain in adults have been traditionally at-
tributed to osteoarthritis (OA), however, advancements
in imaging and arthroscopy have improved health care
providers’ understanding of hip disorders that occur be-
fore the onset of arthritis [1]. Non-arthritic hip disorders
are defined as abnormalities of the articulating surfaces
of the acetabulum and femur before the onset of osteo-
arthritis, including intra-articular structures such as the
acetabular labrum and chondral surfaces [2, 3]. Abnor-
malities of these structures can lead to a continuum of
biomechanical changes and extra-articular adaptations
that can cause significant hip pain and dysfunction in
young adults [3, 4].
Femoroacetabular impingement (FAI) is a common
cause of hip symptoms and impaired functional per-
formance in younger active populations [5]. FAI is a
mechanical disorder characterised by repetitive contact
between the acetabulum and proximal femur, potentially
resulting in damage to the hip joint cartilage and labrum
[6]. FAI comprises several hip-shape abnormalities, in-
cluding CAM and pincer morphology, and has been
suggested as a risk factor for hip OA [7]. However, the
link between FAI and development of hip OA is unclear.
Whilst CAM-type FAI has been shown to be strongly
associated with fast-progression to end-stage OA [8], the
same association has not been demonstrated for pincer-
type FAI and early OA [9]. Therefore, whilst intuitively
appealing to conclude FAI structural changes lead to
joint damage and development of early OA, a causal link
remains unproven [10].
Conservative management of intra-articular hip disorders
To date, patient outcomes after treatment of intra-
articular hip disorders have been limited to post-surgical
outcomes [11, 12]. Consequently, comprehensive treat-
ment outside of surgery remains ill-defined [1]. Although
the success of conservative management for non-arthritic,
intra-articular hip pain is inconclusive [10], positive results
have been reported in two recent publications [1, 13].
Hunt et al. [1] and Emara et al. [13] reported outcomes
of conservative care for patients with clinical indicators
of non-arthritic, intra-articular hip pain. Both studies
demonstrated significant improvements in pain and phys-
ical function from baseline to +1-year follow-up. The ob-
servational nature of these studies prevent speculation on
the mechanisms underpinning the effectiveness of conser-
vative treatment, however, these are important findings
as many experts had previously concluded there was
no role for conservative treatment [10].
A recent systematic review found the experimental
evidence reporting non-operative treatment for FAI is
limited to 5 articles providing a low-level of evidence
[10]. Whilst limited the experimental evidence promotes
physical therapy led care for FAI. Fundamental to all
regimens is an exercise-based programme focused on the
core hip musculature, individually tailored strengthening
exercises, manual therapy, home-based exercise and edu-
cation. In addition, the early use of simple analgesia and
NSAIDs is promoted. Whilst there is a suggestion that this
form of physical therapy and education confer some bene-
fit to patients, the literature is not supported by any
randomised controlled trials, and conservative treat-
ment regimens need to be evaluated more extensively
and rigorously to determine the true clinical effective-
ness [1, 5, 10, 13].
Structure and process of hip pain rehabilitation in the
UK military
Abnormal femoroacetabular morphology is commonly
seen in young men comprising much of the UK military
population [14]. Residential multidisciplinary team (MDT)
rehabilitation for patients with musculoskeletal injuries
has a long tradition in the UK military. Rehabilitation
most often takes place in two clinical settings; out-patient
primary care rehabilitation facilities (PCRF), and specialist
in-patient residential centres. Rehabilitation at the PCRF
is focussed primarily on physical function led by a physio-
therapist, whereas residential centres have access to larger
consultant led multidisciplinary teams delivering a broader
psychosocial approach to treatment. However, whilst
single treatment entities for hip conditions have been the
subject of evidence-based examination, there has been
little evaluation of group-based MDT management pro-
grammes combining single treatments. Aprile et al. [15],
showed no statistically significant difference between
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outpatient/individual versus inpatient/group hip rehabili-
tation for any validated clinical outcome measure. Angst
et al. [16] found comprehensive inpatient team rehabilita-
tion led to statistically and clinically important improve-
ments in pain and function for patients with co-morbid
hip pain. However, there are no studies presenting empiri-
cal data on the structure and process of non-arthritic hip
pain care for a young active military cohort, or whether a
broader residential MDT approach provides better care
than individualised conventional outpatient treatment.
With no available data, the effectiveness of MDT resi-
dential care remains unclear. Therefore, the purpose of
this study is to compare the effects of a residential,
multidisciplinary intervention, to usual outpatient care,
on the clinical outcomes of UK military patients under-
going treatment for non-arthritic intra-articular hip pain.
This protocol describes the design and analysis plan for
a randomised controlled trial.
Methods/design
Study aims and hypothesis
The primary aim of this study is to compare the effects of
a 7-day residential multidisciplinary intervention, to usual
outpatient care, on pain and physical function in military
patients with non-arthritic intra-articular hip pain.
The secondary aims are to assess changes in relevant
musculoskeletal variables of treatment including hip range
of motion (HROM), walking ability, and postural control
during single leg stance. The primary time point is mea-
sured at 3-months (12-weeks).
Primary hypothesis
No studies have compared the effects of MDT residential
rehabilitation interventions versus conventional outpatient
care for non-arthritic hip pain. However, systematic re-
views and RCT’s provide evidence that MDT inpatient
rehabilitation programmes are more effective than usual
care (moderate evidence) to improve pain, well-being and
self-reported function in heterogeneous patient groups
with musculoskeletal conditions [17–20]. Therefore, we
will test the following primary hypothesis:
i. A 7-day multidisciplinary residential intervention
will result in greater improvements in treatment
outcomes compared to individualised outpatient
treatment in young adults with non-arthritic hip pain.
Secondary hypotheses
There is evidence from RCT’s showing that a greater
number of therapist contacts and higher intensity re-
habilitation improves rehabilitation outcomes in patients
with musculoskeletal pathology [21, 22]. This suggests a
dose-response for treatment/training outcomes [23].
Class-based supervised exercise rehabilitation has also
been shown to improve health outcomes compared to a
non-supervised home-based group [24]. In our study a
residential rehabilitation group will receive a period of
intensive, supervised class-based treatment. An outpatient
group will undergo a series of regular clinic appointments
combined with unsupervised home-based exercise. We
will test the following secondary hypothesis:
ii. In patients with non-arthritic hip pain, residential
MDT treatment, compared to outpatient
physiotherapist led care, will result in a significant:
 Improvement in hip muscle strength
(as measured by hand-held dynamometry)
 Increase in hip range-of-motion
(as measured by inclinometer)
 Improvement in health related quality-of-life
(as determined by the EuroQuol-5D)
 Greater adherence to home-based exercise
(as determined by patient self-report diary)
Design
The study is a superiority parallel-group, randomised
controlled trial (RCT) of a 7-day residential, multidiscip-
linary intervention (MTD programme), and individua-
lised physiotherapy outpatient care (IP programme) with
3-month follow-up. Measurements will be taken at base-
line, post-treatment (7-day MDT; 6-weeks IP) and 12-
weeks. We considered including a sham control treatment
group but felt in a well-motivated young military cohort
this could have a negative impact on recruitment. Trial
participants, assessors and clinical/research staff will be un-
blinded to treatment allocation. The protocol will conform
to the CONSORT (Consolidation of Standards of Reporting
Trials) guidelines for non-pharmacological interventions
[25], and principles of the Declaration of Helsinki [26].
Setting
The study will be conducted at a specialist UK military
rehabilitation centre.
Ethics
The study has been reviewed and approved by the UK
Ministry of Defence (MOD) research ethics committee
(study reference protocol 576 dated 01 Nov 2014). Any
requirement for protocol modifications will be submitted
for authorisation to the MOD research ethics committee.
Participants
We will recruit 100 male participants aged 18 to 50 years
attending the Centre for Lower Limb Rehabilitation in-
jury assessment clinic (Defence Medical Rehabilitation
Centre (DMRC), Headley Court, UK) with symptoms of
intra-articular non-arthritic hip pain. Eligible partici-
pants must meet the criteria detailed in Table 1.
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Procedure
The procedure and flow of participants is outlined in
Fig. 1. Patients with symptoms of hip pain will undergo
preliminary screening conducted by their local unit
medical officer. The only screening criteria used at this
initial stage is the patient reporting symptoms of hip/
groin pain for at least 3-months. Potential participants will
then attend a multidisciplinary injury assessment clinic
(MIAC) at DMRC for a comprehensive musculoskeletal
examination by a specialist rehabilitation consultant, and
experienced musculoskeletal physiotherapist. The purpose
of the MIAC is to establish the patient’s eligibility for inclu-
sion in the study. Because attendance at the MIAC is
directly linked to this study, patient consent to attend the
MIAC will be sought in advance via postal consent forms
and a patient information sheet, and follow-up telephone
calls from study administrators where necessary. The infor-
mation sheet will detail the nature of the study and will
include confirmation that consenting eligible participants
will be randomly assigned to one of the following two
treatment groups:
i. Group 1- MDT residential intervention.
Participants will receive an intensive, 7-day residential
(in-patient) intervention at DMRC Headley Court. The
intervention will include group-based exercise, manual
therapy, hydrotherapy and education. The intervention
will be delivered by a multidisciplinary team comprising
a consultant physician, physiotherapist (PT),
occupational therapist (OT) and exercise rehabilitation
instructor (ERI). The intervention is anchored by
admission and discharge procedures at day one and
day seven respectively. Participants will typically
complete seven therapy sessions each day of 30–60
mins duration over the remaining 5 days. The sessions
enhance social contacts through group-based feedback
before and after treatment, and by promoting partner
and group exercise [27].
ii. Group 2- IP outpatient intervention. Participants
will receive 8 treatment sessions, delivered over
6-weeks, combined with a home-based exercise
programme. The first and last treatment session
will be 45–60 min in duration. The remainder
will be 30 min. The intervention will include
individualised exercise, manual therapy and
individually tailored education/advice. This
programme will be delivered as an outpatient
service from DMRC and led by an experienced
physiotherapist. The treatment session duration
reflects a realistic treatment dosage in clinical
practice and has been shown sufficient to allow
all components of treatment to be carried out [28].
Delivering the intervention in this realistic setting
is important to determine the likelihood of
effectiveness of the intervention in everyday
practice [29]. The home-based programme will
initially comprise 3-sessions per week but can be
adjusted by the physiotherapist in response to patient
progress. The home-based exercise programme in
this study will be restricted to 3-times per week based
upon the limited available evidence from clinical trials
in non-arthritic hip pain [30], and a compromise
between addressing the clinical goals whilst optimising
adherence [31]. The home-based programme will
be tailored to the individual needs of the patient,
and utilise self-monitoring by means of an
exercise diary.
Table 1 Study eligibility criteria
Inclusion criteria
1. Anterior or lateral hip pain for at least 3-months
2. Clinical signs and symptoms of prearthritic intra-articular hip
pathology/FAI diagnosed by a specialist Consultant Physiciana
3. Physical examination findings or reproduction of pain in the groin
or lateral hip with the log roll, anterior hip impingement test,
Thomas test or resisted straight leg-raise testb
4. Sufficient time to keep therapeutic appointments




2. Hip infection or tumour
3. Hip fracture including history of stress fracture
4. Existing extra-articular hip disorders and/or any other pre-existing
hip pathology
5. Major structural deformity of the hip
6. Advanced degenerative disease of the hip
(Tönnis classification 2–3) [27]
7. Any physical impairment or co-morbidities
(including cardio-vascular disease) precluding the safe participation
in the rehabilitation programme and/or assessment procedures
8. History of congenital/adolescent hip disease
9. Cortico-steroid or analgesic injection intervention for hip within
the previous 30-days
10. Clinical signs of lumbar spine disease including radiculopathy
11. Insufficient capacity to provide informed consent
12. Aged ≥ 50 years
13. Female
aConsultant diagnostic criteria will include [1] anterior or lateral hip pain for a
minimum of 3-months; [2] history of pain worsening with activity, pivoting, hip
flexion or weight bearing; [3] pain associated mechanical symptoms including
popping, clicking or locking; [4] pain at rest; [5] physical examination findings
or reproduction of pain in the groin or lateral hip with the anterior hip impingement
test; [6] physical examination findings that exclude the spine and other lower-limb
disorders as a potential source of pain and dysfunction; [7] patient self-report of
sensations of instability during functional movements (e.g., squatting)
bMeasurement techniques and positions are described at appendix 10 of the
Additional file 1
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A definition of rehabilitation based on the concepts of
structure and process is frequently used when assessing
the content of health care interventions [32]. In our study
the therapeutic content (e.g., exercise, manual therapy,
education, home-based programme) is the same for both
study groups. However, the structure and process will
differ significantly. The residential arm is group treatment
delivered by a MDT in a residential setting over 7-days.
The outpatient arm is physiotherapist led individual treat-
ment delivered during a series of weekly appointments
over 6-weeks. Therefore, the amount of direct therapist
contact, hands-on physical therapy and instructions
surrounding exercise adjustment and education will differ.
A detailed description of the treatment methods is con-
tained in Table 3 and Additional file 1.
Eligible patients will be invited to participate in the
study and complete an informed consent form. Patients
agreeing to participate will be informed of treatment
group assignment and referral arrangements by a civilian
member of the clinical team, and all necessary study
documents will also be provided. Ineligible patients will
receive an ongoing referral in accordance with the existing
UK military best practice care pathway. Following con-
sent, participants will be consecutively randomised into ei-
ther the residential or outpatient group by an independent
administrator not involved in recruitment, assessment or
Fig. 1 Participant flow through the study. DMRC = Defence Medical Rehabilitation Centre; IP = individualised (outpatient) programme;
MDT = multidisciplinary team (residential); MIAC = multidisciplinary injury assessment clinic
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treatment of participants. Baseline testing will be con-
ducted immediately prior to commencement of treatment.
Participants will be reassessed on completion of treatment
(1-week (MDT); 6-weeks (IP)), and again at 12-weeks
(week 12). During the 12-week follow up period, all
participants will be advised to continue with an unsuper-
vised home exercise programme. A log book record of ex-
ercise participation will be maintained during this period,
and participants will be asked to refrain from seeking
other treatments during the study.
Randomisation and treatment allocation concealment
A block randomisation method will be used to randomise
subjects into groups that result in equal sample sizes. This
method will ensure a balance in sample size across both
groups over time. Blocks are small and balanced with pre-
determined group assignments, which keeps the numbers
of subjects in each group similar at all times, whilst ensur-
ing there is a 50:50 likelihood of participants being allo-
cated to either group. Due to the possible influence of
gender on the efficacy of strengthening exercise [32, 33],
the study will only recruit male participants. After patient
eligibility has been confirmed and informed consent ob-
tained, a sealed envelope will be opened to reveal group
allocation by an independent administrator not involved
in the recruitment, treatment or assessment of study out-
comes. A plain language statement will inform partici-
pants that they have an equal chance of receiving the
residential MDT or individualised outpatient intervention.
Group allocation will be documented and communicated
to the supervising therapists by the independent adminis-
trator. Prior to the study, all treating staff will have re-
ceived a briefing on the study protocol, the ethical, clinical
and scientific basis of the study, the randomisation process
and specific intervention for each treatment group, in line
with the study protocol. It is not possible, relevant or
necessary to blind participants to treatment allocation in
this study. The clinical staff supervising both groups will
be, by necessity, unblinded. Day and Altman [34] suggest
blinding assessment by using non-involved assessors to
record outcome scores. This is not possible in our study
as independent assessors with specific knowledge of quan-
tification of clinical outcomes are not available due to
specialist staff man-power limitations. To minimise the
potential influence of outcome assessors, instructions are
standardised to ensure consistency in measurement. A
medical statistician assisting with statistical analysis
will be blind to group allocation until completion of
the analysis.
Interventions
The content and protocols for the study interventions
are described in a MILO study intervention guide [see
Additional file 1]. Table 2 provides a summary of the
components of the MDT residential intervention. Table 3
provides an overview of the IP and MDT treatment
schedules. Following the recommendations of Bennell et
al. [29], a systematic approach to designing all aspects of
the intervention has been adopted that ensures it is
based on theory, evidence, reflects elements of best prac-
tice, and is reproducible and reportable. The MDT resi-
dential and IP outpatient group programmes in this
study will employ a semi-structured protocol, which pro-
vides guidance on exercise prescription, but can be tai-
lored to meet individual patient assessment findings and
progression. Written guidelines for individual tailoring
of activity and treatment prescription will be provided to
supervising therapists. Designing a patient care plan that
is individually tailored from a standardised menu of in-
terventions ensures our methodology is consistent with
the ‘ideal standard of clinical practice’ [35], and research
designs of previous studies [5, 27, 29, 36, 37]. The IP
outpatient intervention will be administered by a senior
chartered physiotherapist. A broader MDT including
specialist physician, physiotherapist, occupational thera-
pist, exercise rehabilitation specialist and nutritionist at
DMRC will deliver the residential programme. All treat-
ing therapists will attend a training session at DMRC
which will focus on the exercise, manual therapy and
education interventions to ensure a standardised ap-
proach to treatment across both interventions and
therapy staff. Whilst the delivery of therapeutic interven-
tions by several MDT staff risks an increase in treatment
variation through the influence of therapist personality
and style, it allows a more practical delivery mode that
mimics clinical practice, and will enhance the generalisi-
bility of study findings [5].
The goals of treatment are the same for both the resi-
dential and outpatient groups. The specific programme
design will differ to reflect the contrasting structure in
each setting, and to accommodate the individual partici-
pant progression. The core components of treatment are
as follows:
Exercise therapy
It is beyond the scope of this study protocol paper to detail
every individual exercise used in the study interventions.
The exercise programme incorporates strengthening, flexi-
bility/range of motion, and functional balance and neuro-
muscular control exercises in accordance with current
evidence-based guidelines, and exercise recommendations
for the conservative management of intra-articular hip
disorders [1, 10, 13].
Muscle strengthening exercise
A key component of the exercise programme is local sta-
bilisation of the hip joint by retraining and strengthening
of the global hip musculature. We will implement a
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comprehensive strengthening programme to optimise
neuromuscular control, strength and stability of the hip.
This includes exercises targeting gluteus medius, gluteus
maximus, iliopsoas, quadratus femoris, obturator inter-
nus, inferior and superior gemelli, adductor brevis and
pectinius [38]. We will also include core strengthening
based on studies of hip muscle activity during the per-
formance of core exercises [39], and its recommendation
in clinical guidelines for the management of non-arthritic
hip pain [40]. We also include functional, weight-bearing
hip muscle strengthening including some proprioception
exercises to optimise neuromuscular control, stability and
strength of the hip in patient specific (military) activities.
The programme acknowledges the importance of the deep
hip rotators and gluteal group. These muscles act as deep
stabilisers to steady the femoral head in the acetabulum,
and provide dynamic control of hip joint stability [41].
The focus of the strengthening programme is based on low
load exercise, commencing in non-weight bearing positions,
4-point kneeling, and progressing to fully weight-bearing
functional positions promoting global muscle recruitment
[1, 5]. Three sets of 8–12 repetitions are completed for each
exercise. Graduated exercise progression is determined by
the supervising therapist based upon participant feedback,
re-assessment and individual response to training.
It should be noted that despite an abundance of informa-
tion on the implementation of strength and conditioning
principles with healthy participants, investigation regarding
the application of these principles in rehabilitation pro-
grammes is lacking [42]. The dosage for strengthening
exercises in this protocol aims to meet the ongoing chal-
lenge of designing treatment programmes that facilitate
neurological and muscular adaptations whilst concurrently
accommodating biological healing, recovery and the safety
of the patient. The justification for the initial dosage of
3 × 8-12 repetitions takes account of the evidence sug-
gesting pain provoked by exercise has been shown to re-
duce adherence to exercise in rehabilitation programmes
[43, 44]. The study intervention programmes aim to sta-
bilise pain within a given range-of-motion during the early
stages of rehabilitation. Therefore a relatively conservative
initial dosage is chosen that should allow a short period of
adaptation whilst controlling for pain, thereby promoting
exercise adherence. This repetition range has been recom-
mended and used for strength exercise prescription in
recent RCT protocols/studies for non-arthritic hip pain
[5, 30, 45] and hip OA [27, 37, 46]. None provided refe-
rences to sources of experimental evidence supporting
selection of this exercise dosage, however, in two studies
[27, 30] improvements in pain and function were reported
following this programme.
Stretching and range of motion exercise
Decreased range-of-motion (ROM) is common in pa-
tients with intra-articular hip pain and osteoarthritis
(OA) [47]. Muscle stretching exercises will target the hip
Table 2 Multidisciplinary team (MDT) residential intervention – components of treatment
Treatment modality Treatment content Treatment goals Frequency per week
(duration)
Group exercise Strengthening exercises, active range of
motion exercises, functional balance drills,
gait drills, progressive co-ordination drills,
non-weight-bearing aerobic/endurance
exercise, minor team games.
Restore strength of deep hip stabilisers,
improve core strength, increase joint
range of motion, improve balance and
neuromotor control, improve muscle
endurance, promote group cohesion
and social support.
12 (30–45 min)
Individual physiotherapya Manual therapy techniques, muscle
activation and timing patterns, active and
passive range of motion exercises, advice
on home-exercise, gait re-education training.
Improve quality and timing of movement,
improve muscle strength, reduce pain,
increase joint range of motion, induce
relaxation, promote normal walking gait.
5 (30 min)
Hydrotherapy/swimming Non weight-bearing aerobic exercise,
strengthening exercises, active range of
motion exercises, self-paced recreational
swimming, progressive/assisted weight-
bearing exercise and activity.
Improve muscle strength, improve aerobic
capacity, increase joint range of motion,
improve confidence in weight-bearing,
induce relaxation, promote enjoyment
and variety of treatment.
3 (60 min)
Individual occupational therapyb Relaxation techniques, postural re-education,
cognitive behavioural therapy (CBT)
techniques, self-help coping strategies,
pain management.
Induce relaxation, promote behavioural
change, control pain, correct/improve
poor posture.
3 (60 min)
Patient education Coping with pain, benefits of exercise, joint
protection, anatomy and pathology of hip
pain, nutrition.
Activity modification, reduction of pain,
promotes behavioural change, weight
management, improve knowledge of
treatment options, improve ability to relax,
improve knowledge of self-help techniques.
2 (60 min)
aExercise dosage, progression and intensity will be governed by the physiotherapist and tailored to the needs of each individual patient; bOccupational therapy
referrals will be individually prescribed to selected patients
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flexors, hip extensors, abductors and adductor groups to
address and maintain hip extension, flexion, adduction/
abduction and internal/external rotation. Static and ac-
tive stretching and foam-roller techniques are employed
to emphasise the ROM needed for activities of daily
living. Perception skills and dissociation (joint isolation
exercises) are trained to allow proper exercise execution
and enhance motor control [27–30]. Retraining optimal
control of hip abductor muscles, plus stretching for tight
flexor muscles may also contribute to a reduction in
destructive joint forces and thereby reduce pain [29].
Neuromuscular control and functional balance exercise
Proprioceptive deficits routinely occur in conjunction
with articular injuries of the hip [48]. Labral injuries lead
to an inhibited motor response and decreased neuro-
muscular stabilisation of the joint [49]. Balance and pro-
prioceptive exercises will be included to restore these
deficits and re-establish neuromotor control. Progression
is applied by increasing the complexity and difficulty of
the exercise, by reducing the base of support, adding dy-
namic movements on unstable surfaces, and increasing
the range through which the movement is performed.
Support for neuromuscular training in hip rehabilitation
has been reported in the literature [48].
Aerobic exercise
Participants will undertake light to moderate aerobic con-
ditioning over the intervention period. In addition to the
general health benefits conferred by aerobic exercise,
moderate joint loading has been shown to be beneficial
for joint health because of mechanosensitive chondropro-
tective pathways [50]. No study has described the optimal
dose of aerobic exercise for patients undergoing hip re-
habilitation in terms of intensity, volume and duration
[47]. In this study, the supervising physiotherapist will de-
termine the nature of aerobic exercise (walking, cycling,
swimming, cross-trainer), and progression in intensity
based on individual examination finings and patient re-
sponse to exercise. In patients with a differential diagnosis
of FAI, static cycling will be undertaken with caution and
Table 3 Overview of Outpatient Individual Programme (IP
Group) and Residential (MDT Group) Study Treatment Schedule
Outpatient (IP) Protocol Residential (MDT) Programme
Session 1 (45–60 mins)a Day 1
• Subjective and objective
assessment (20–25 mins)
• Admission MDT clinic and
baseline measures
• Patient education (5-mins) Day 2
• 1–2 manual therapy techniques
(5–10 mins)
• Group-based introduction
to treatment goal 1
• Teach target exercise from
treatment goalsc 1 and 2
(15–20 mins)
• Group-based introduction
to treatment goal 2
• Confirm home-exercises (5-min) • Individual therapy appointments
in accordance with patient
timetable (PT/OT)b
Session 2 (45–60 mins) Day 3
• Subjective and objective
re-assessment (10-mins)
• Group-based introduction to
treatment goal 3
• Patient education (5-mins) • Group-based introduction to
treatment goal 4
• Manual therapy techniques
(15–20 mins)
• Group-based education topic 1
(‘about hip pain’)
• Teach revised home exercises;
check log-book (15–20 mins)
• Individual therapy appointments
in accordance with patient
timetable (PT/OT)
Sessions 3 to 8 (30–40 mins) Day 4
• Subjective and objective
re-assessment (5-mins)
• Group-based introduction to
treatment goal 5
• Manual therapy techniques
(15-mins)
• Consolidate individual patient
exercise programme
• Patient education & advice
(5-mins)
• Group-based education topic 2
(‘activity modification’)
• Progress home-exercises; check
log-book; address adherence
issues (15-mins)
• Individual therapy appointments
in accordance with patient
timetable (PT/OT)
Day 5
• Group-based exercise targeting
individual patient priorities
• Group-based education topic 3
(‘benefits of exercise’)
• Individual therapy appointments
in accordance with patient
timetable (PT/OT)
Day 6
• Group-based exercise targeting
individual patient priorities
• Group-based education topic 4
(‘pain management’)
• Individual therapy appointments
in accordance with patient
timetable (PT/OT)
Day 7
• Confirm individual home-based
exercise programme; issue
log book;
Table 3 Overview of Outpatient Individual Programme (IP
Group) and Residential (MDT Group) Study Treatment Schedule
(Continued)
• Discharge clinic with
multi-disciplinary team
Follow-up period Follow-up period
• 4 to 6 home exercises,
3-times per week
• 4 to 6 home exercises,
3-times per week
aTiming does not include baseline outcome measures; bPT = Physiotherapist;
OT = Occupational Therapist; c Explanation of treatment goals are contained in
Additional file 1
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an elevated seat to avoid combined deep hip flexion and
internal rotation [13].
Manual therapy
Manual therapy techniques will be used to modify the
quality and range of motion of the hip and associated
soft tissue structures, and assist with pain relief. The
manual therapy intervention will be prescribed individu-
ally for each participant on the basis of the physical
examination findings, from a limited list of techniques
including trigger point massage, passive joint mobilisa-
tion, distraction and sustained stretches. These tech-
niques are informed by evidence-based best practice and
are commonly used in the management of hip dysfunc-
tion [5, 30, 36]. Lumbar spine mobilisation, in the form
of passive accessory intervertebral movements, will be
performed in those patients where the physiotherapy
assessment identifies a requirement [5].
Education
Educating the patient on factors surrounding their treat-
ment and the importance of regular exercise could be a
key element for patient adherence to a home-based exer-
cise programme [51, 52]. Education and advice will be a
focus of the intervention and will include information
on diagnosis and aetiology of FAI/hip pain, rationale for
treatment, the benefits of exercise, joint protection and
activity modification strategies, pain management, coping
with acts of daily living (sitting, driving, sleeping, work),
and the importance of increasing physical activity levels in
everyday life. The contents of the education component
will be evidence-based [10, 40] with the overall focus di-
rected towards increasing the knowledge of the participant
on issues surrounding their condition.
Home-based programme
Participants will be instructed to complete an individua-
lised, unsupervised home exercise programme during the
12-week follow-up period. This programme is prescribed
by the physiotherapist at the final treatment session. To
optimise adherence, the programme will comprise four to
six exercises performed three times per week [29, 30, 35].
The selected exercises will reflect the patient’s clinical pri-
orities for treatment determined by the physiotherapist on
completion of the supervised phase of the protocol. The
home exercise programme will comprise any combination
of strengthening, stretching, neuromuscular control and
aerobic exercise. The starting level will reflect the partici-
pant’s functional capabilities upon commencement of the
follow-up training period. Guidance on exercise progres-
sion will also be provided, and participants will receive
written instructions demonstrating the home exercises.
Participants will be asked to report all training sessions in
training diaries. Diary records will be used to measure
compliance to the home programme. A goal is that
participants should complete a minimum of 80 % of the
prescribed exercise sessions [50].
Outcome measures
Outcome measures with proven validity and reliability
have been selected based on those recommended for clin-
ical trials of intra-articular FAI [53], and current practice
in UK military rehabilitation [54]. Standardised instru-
ments recommended by OMERACT-OARSI guidelines
[55] will also be included. These guidelines require mea-
sures of pain, physical function and a global assessment of
health related quality of life. Participants will be assessed
at baseline, on completion of treatment (1-week MDT
group; 6-weeks IP group) and 12-weeks follow up (Fig. 1).
The follow-up time-frames are the same for both groups
(12-weeks), and all participants will be assessed at baseline
and 12-weeks on the same clinical outcome measures.
The inclusion of post-treatment measures may help reveal
if any differences occur as a consequence of the different
interventions (e.g., the immediate post-treatment scores
by group). All outcome measures will be conducted, ad-
ministered and overseen by the same supervising therapist
on each occasion. Outcome measures used in the study
are summarised in Table 4.
Table 4 Summary of outcome measures
Primary outcome measurea Data collection instrument
Function in daily living Subscale of HAGOS
Physical function, activity level Subscale of HAGOS
Hip symptoms, numeric
pain rating
Subscale of HAGOS, subscale
of NAHS, VAS
Secondary outcome measuresa
General health status EuroQol -5D (EQ-5D-3 L)
Mood, anxiety, depression HADS
Objective functional performance 6-minute walk test
Hip range of motion Clinical methods and goniometry
Dynamic balance/postural control Modified Star Excursion
(Y-Balance) Test
Hip muscle strength Hand held dynamometry
Treatment efficacy & self efficacy SIRBS
Adherence to home-based
exercise





aThe primary end-point for data analysis is 3-months. All measures will be
taken at baseline, post-treatment (1-week MDT group; 6-weeks IP group),
3-months with the exception of patient demographics which will only be
assessed at baseline
HAGOS Copenhagen Hip and Groin Outcome Score, NAHS non-arthritic hip
score, VAS visual analogue scale, HADS hospital anxiety and depression scale,
SIRBS sports injury rehabilitation beliefs survey
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Descriptive data
Personal and demographic characteristics including age,
height, body mass, body mass index (BMI), gender,
duration of symptoms, previous injuries, previous treat-
ments, medication use, military occupation, duration of
military service, smoking and drinking habits, and sporting/
exercise participation will be obtained by questionnaire.
The primary outcome measures and instruments will be:
The Copenhagen Hip and Groin Outcome Score
(HAGOS). The Copenhagen Hip and Groin Outcome
Score (HAGOS) was developed in 2011 and is
specifically designed for young to middle-aged,
physically active individuals with hip and groin pain
[56]. This patient-reported questionnaire is a quantitative
measure of hip disability based on the different levels of
the International Classification of Functioning, Disability,
& Health. The HAGOS contains 37 questions, covering
six domains: pain (10 items), symptoms (7 items),
physical function in daily living (5 items), physical
function in sport and recreation (8 items), participation
in physical activities (2 items), and hip and/or groin-
related quality of life (5 items). Construct validity
and responsiveness to change have been shown with
statistically significant correlation coefficients of 0.37
to 0.73 (P < 0.01) for convergent construct validity and
from 0.56 to 0.69 (P < 0.01) for responsiveness [57].
The HAGOS was selected because it is designed to
assess changes from week to week induced by physical
therapy [58] in a young to middle-aged population
approximating the demographic characteristics of our
target sample.
The Non-Arthritic Hip Score (NAHS). The non-
arthritic hip score (NAHS) comprises 20 questions
covering four domains: pain (five items), symptoms
(four items), acts of daily living (ADL; five items), and
physical activities (six items). The questionnaire was
developed for the assessment of hip pain in young
participants with increased activity demands [59].
Several questions related to mechanical symptoms
and physical activities relevant to active military
patients are included. Convergent construct validity
has been confirmed with a statistically significant
correlation coefficient of 0.82 [57]. The NAHS is
currently used within UK military rehabilitation, and
scales of this kind are frequently used as an external
criterion for comparison with changes in scores of
other outcomes [5]. Therefore, the NAHS will be
used to assess similarity of results with other
self-reported measures included in this study.
The Visual Analogue Pain Scale. A visual analogue
scale (VAS) will be used to measure pain intensity.
The patient will be asked to rate their worst hip/groin
pain experienced over the past 24-h using a 100 mm
horizontal VAS anchored by the terms ‘no pain’ and
‘worst pain possible’. The supervising physiotherapist
will also enquire if the sensation of pain is sharp or a
dull ache, and if pain is made worse by movement.
The 100-point VAS scoring requires no mathematical
transformation, and with a normal distribution of data,
it allows for parametric statistical analysis [60].
The VAS response format has shown good internal
consistency, is easy to understand, is in wide clinical
use, and has been sufficiently evaluated in clinical
trials [60, 61].
The secondary outcome measures and instruments
will be:
EuroQuol-5D(EQ-5D-3L). The EQ-5D is a
standardised, validated questionnaire for the self-rating
of a patient’s health status [62]. It comprises a visual
analogue scale (VAS) measuring self-rated health and a
health status instrument consisting of a three-level
response (no problems, some problems and extreme
problems) for five domains [63]; (a) mobility, (b) self-
care, (c) usual activities, (d) pain and discomfort and
(anxiety and depression). A respondents EQ-VAS gives
self-rated health on a scale where the endpoints are
labelled ‘best imaginable health state’ (100) and ‘worst
imaginable health’ (0). The EQ-5D has been shown to
provide more exact ratings of everyday activities and
their disease-related restrictions compared with other
measures of health related quality of life (QOL) [64]. The
inherent consistency of the EQ-5D test has been evaluated
in the literature and shown good responsiveness to change
in patients with hip conditions [65], and has been used in
similar populations with similar musculoskeletal
complaints to our study population [66].
Hospital Anxiety and Depression Scale (HADS).
This self-report questionnaire measures mood disorder
and is validated for use as a screening tool in the
general population [67]. It contains 14 items, seven
relating to anxiety and seven relating to depression,
which are scored separately. A score of 0–7 indicates
no anxiety or depression, 8–10 is viewed as ‘borderline’
and 11–21 indicates the presence of anxiety or depression
[36]. Previous research has demonstrated a link between
hip OA and psychological wellbeing [68]. The HADS
will be used to identify if anxiety or depression are
confounders to treatment response and predictors of
treatment outcome.
6-Minute Walk Test. Physical performance measures
should be used in combination with self-report
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measures in the assessment of physical function [69].
The 6-minute walk test (6MWT) measures the
distance an individual is able to walk over a total of
6 min on a hard, flat surface [70]. The goal is for the
individual to walk as far as possible (measured by
metres covered) in 6 min. The individual is allowed to
self-pace and rest as needed as they traverse back and
forth along a marked walkway. Timed walk tests have
previously been used as a direct measure of physical
performance in exercise-based osteoarthritis trials
[36, 71], with positive inter-rater reliability [ICC 0.95
(CI:0.90, 0.98)] reported in one hip OA study [72].
The Modified Star-Excursion Balance (Y-Balance)
Test. Impaired standing balance has been reported
in people with hip pain compared with age matched
healthy controls [73], and the exercise intervention in
this study aims to correct poor balance and postural
control. Dynamic balance and postural control will be
measured using the modified star excursion balance
test (SEBT), known as the Y-Balance test [74]. The test
is performed with the participant standing on one leg
and then reaches with the free limb as far as possible
along three lines positioned in anterior, posteromedial,
and posterolateral directions (Fig. 2). The Y-Balance
Test was developed to standardise performance of the
SEBT incorporating those directional movements with
the greatest accuracy in identifying lower extremity
dysfunction [75, 76]. The test has demonstrated good
intra-rater reliability with reliability coefficients (ICC
2,1) ranging from 0.67 to 0.96 [62], and is currently
used as a measure of postural control in patients
undergoing UK military hip pain rehabilitation [54].
Hip Range of Motion (HROM). Loss of range of
motion is a common clinical finding in hip OA and
intra-articular hip disorders, and is associated with
pain and disability [1, 2, 36, 40]. Passive range of
motion will be measured on both sides for hip flexion,
abduction and medial rotation using a high precision
inclinometer. Individual scores will be recorded and
used for analysis purposes. High test-retest reliability
values have been reported (0.82, 0.86, and 0.90
respectively using the intra-class correlation co-efficient
(ICC)) in subjects with hip OA [36, 77]. Whilst this
is a standard assessment commonly employed in the
clinical setting, consistency in measurement technique
will be confirmed during a 1 day training session
at DMRC prior to commencement of the study.
A description of testing positions and techniques is
provided in Additional file 1.
Hip Muscle Strength. Strength assessment plays an
important role in the clinical examination of the hip
[78, 79]. Muscle strength measurement in this study
will be analysed in parallel with the assessment of
physical function to establish the contribution
changes in muscle strength may have on functional
performance. Hip muscle strength will be measured
on both sides for flexion (FL), extension (EX),
abduction (AB), adduction (AD), internal rotation
(IR) and external rotation (ER). Strength measures
will be taken using hand-held dynamometry (HHD).
Participants will be tested on a clinical examination
couch in either a seated or supine position depending
on the movement being measured. Test positions
were chosen based on procedures often applied in
the clinical setting [79–81]. In accordance with the
description of Thorborg et al. [78] an isometric
‘make-test’ will be used for testing. This test was
chosen as isometric loading induces less stress on
the musculoskeletal system than eccentric loading
(‘break-test’), which is a key consideration when testing
individuals with a physical injury [79]. A long lever
arm will be utilised during the six individual tests
wherever possible to ensure the tester’s strength
exceeds the isometric force applied by the participant.
For each movement the examiner will apply resistance
in a fixed position whilst the participant exerts a
5-s isometric maximal voluntary contraction (MVC)
against the dynamometer and the examiner.
Participants will perform four consecutive attempts
for each movement with a 30-s recovery between
attempts. Strength measures will be reported as
Newtons (N). The highest value will be used for
analysis purposes. Good interrater reliability
(ICC 0.76–0.79) and low test-retest variation (<10 %)
has been demonstrated for the HHD measurement
technique in measuring hip muscle strength [78, 81].
Descriptions of measurement techniques are provided
at appendix 10 in Additional file 1.
Sports Injury Rehabilitation Beliefs Survey (SIRBS).
The purpose of the education programme in this study
is to empower patients to manage their own pain and
Fig. 2 Y-balance test. From a single-leg stance the participant reaches
the freely moveable limb along a line in the a anterior, b posterolateral,
and c posteromedial directions
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to maintain physical function. Perceived self-efficacy is
defined as a person’s judgement or belief of their ability
to change, manage or execute tasks related to pain [82].
Several studies have found that a patient’s perceived
self-efficacy is related to health outcomes and the
course of disease progression [82, 83]. The Sports
Injury Rehabilitation Beliefs Survey (SIRBS) [84] is a
19-item instrument that contains five subscales
assessing severity, susceptibility (threat appraisals),
treatment efficacy, and self-efficacy (coping appraisals).
Ratings are made on a 7-point Likert-type scale
ranging from 1 (very strongly disagree) to 7
(very strongly agree). In this study, only the treatment
efficacy (4-items), and self-efficacy (4-items) subscales
will be used. Acceptable alpha coefficients have been
reported for treatment efficacy (0.85) and self-efficacy
(0.91) [85], and low-to-moderate interscale correlations
provide some support for its construct validity [84].
Adherence to Home Exercise. Low adherence to
home based exercise programmes is widely accepted
as a key contributor to poor long-term clinical
rehabilitation outcomes [85, 86]. To measure
adherence during the 3-month follow-up period,
participants in this study will be asked to maintain
a diary/log-book recording the frequency, duration
and intensity of the exercises in their home-based
programme. Participants will also rate their adherence
to the home programme at 3-months on an 11 point
rating scale (with 0 being ‘not at all’ and 10 being
‘completely as instructed’). This method of measuring
adherence to home-based exercise has previously
been used in hip rehabilitation randomised controlled
studies [5, 29].
Sample size
The primary endpoint will be change from baseline to
12-weeks in (a) the HAGOS ‘physical function in daily
living’ subscale and (b) VAS numeric pain rating. Sample
size calculation is based on clinically relevant changes
over the study period (e.g., score changes between base-
line and follow-up should be, on average, subjectively
perceptible by the participant). The minimum clinically
important difference (MCID) in the HAGOS subscale
has been suggested to be 4.8–5.2 points [53]. Between
participant standard deviations have not been widely re-
ported for the VAS using intra-articular hip pain patients
[1, 10]. Therefore, the required sample using a MCID of
5.2 between groups on the HAGOS subscale and a
standard deviation of 11 points, with a significance level
of 0.05 (2 tailed) and a power of 80 %, is 43 per group.
Allowing for an estimated drop out rate of approxi-
mately 15 % at the 12-week follow-up, a total of 100 par-
ticipants will be recruited into the study. Based on
current referral rates it is anticipated this sample target
will be met from routine referrals to DMRC Headley
Court and no additional strategies to promote enrol-
ment are required. The sample size was calculated
using G*Power software Version 3.0.10 (Franz Faul, Uni-
versitaet Kiel, Germany). There is currently no RCT
reporting the effects of a residential MDT intervention
versus outpatient individualised treatment approaching
this sample size in the available literature.
Statistical analysis
The statistical analysis will be undertaken in accordance
with the intention-to-treat (ITT) principle. The ITT ana-
lysis will include all participants, including those who do
not fully adhere to the protocol and those with missing
outcome data. A per-protocol analysis will also be per-
formed where appropriate. Demographic and clinical
characteristics as well as baseline data will be presented
to assess the baseline comparability of the two groups.
Differences from baseline to each time point will be
calculated for all primary and secondary outcomes.
Descriptive statistics will be presented for each group as
mean change, standard deviations and confidence inter-
vals (CI) for continuous variables, and frequencies and
percentages for categorical variables. A longitudinal re-
peated measures design will be used to assess changes
from baseline, and to make between group comparisons
for the continuous outcome measures. Between group
comparisons will be made immediately post treatment
(1 week residential group; 6 weeks outpatient group)
and at 12 weeks.
The effect of the interventions over time will be com-
pared using linear and mixed models. These models are
chosen as they appropriately adjust for correlation that
occurs from collecting multiple observations per partici-
pant [37]. At the 1,6 and 12 week time points, continu-
ous variables will be analysed using a mixed model
repeated-measure analysis of variance (ANOVA) model
(with treatment as the between group factor and time as
the repeated factor). The non-parametric equivalent or
data transformation will be used if non-normal distribu-
tions apply. Where significant differences occur, post-hoc
comparisons will be conducted using Tukey’s multiple
comparison procedure. Differences in nominal/ordinal
data will be analysed using the χ2 test. A significance level
of 0.05 will be set for any inferential statistics conducted.
The inclusion of the post treatment (T2) measure may
help reveal if any differences occur as a consequence of
the different interventions (as T2 reflects the immediate
post-treatment scores for each group). However, this is
based on the assumption that any changes in outcome
from T1 and T2 (over 1 and 6-weeks) are linear, and also
between T2 and T3. We recognise if the trend is non-
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linear then we will have insufficient data points to model
the outcome over time in a way that will enable us to
compare the trajectory of patient outcomes using the 3
time points. If interim analysis reveals this to be the case,
we will remove T2 measures from the final analysis.
Secondary analysis will be undertaken to assess the
predictors of outcome at the primary endpoint (12 weeks
post treatment commencement) in both groups, using
multiple regression analysis. Predictor variables includ-
ing age, gender, baseline pain, physical function, duration
of symptoms, mood/anxiety, self-efficacy, co-morbidities
and exercise adherence will be measured. Analyses will
be performed separately for MDT and IP group treat-
ments. Response variables will be change in HAGOS
function in daily living score pre and post intervention
(MCID > 5.2 points) and numeric pain rating on the
VAS. All predictors will be checked for collinearity. Uni-
variate logistic regression will be performed on all poten-
tial predictors and those associated with the outcomes will
be entered into the multivariate logistic regression model.
Variables with the lowest predictive value will be removed
from the model if p > 0.05. Odds ratios and 95 % CI’s will
be calculated for all final predictors.
No statistical adjustment will be made for multiple
testing. All tests will be two-sided and carried out at the
5 % level of significance. Changes to the study design or
analysis plan will be documented with full justification.
A statistician will oversee the blinded analyses of the
data. The statistical analysis procedure will be discussed,
reviewed and co-worked with statisticians at the Depart-
ment for Health University of Bath, and School of Clinical
Sciences at Bristol University.
Data storage and quality assurance
All information obtained in the conduct of this study
will be treated as confidential and participant anonymity
will be ensured throughout the study period. Electronic-
ally stored data will be identified by a password-protected
participant ID code unique to the study. We will tran-
scribe data from paper forms directly into a bespoke
Military Hip Rehabilitation Outcome (MILO) study rela-
tional database (Concentrica Ltd, Cambridge, UK) based
on server’s in the Academic Department of Military
Rehabilitation, DMRC and the Department for Health,
University of Bath. To minimise transcription error, we
will use manual double data entry. RC, JB, AW and AB
will have access to the final trial dataset.
Adverse events
All researchers involved in the conduct and supervision
of this study will receive extensive training in all aspects
of the administration of the trial protocol. The training
will comprise a 1-day programme delivered at DMRC
Headley Court. All clinical and research staff will receive
a brief detailing the procedures for identifying and
reporting safety issues including the use of project ad-
verse events forms. They will be informed of the role
and responsibilities of the Independent Medical Officer
(IMO) and the lead researcher who takes day-to-day
responsibility for safety of the project. Reporting of
safety incidents will be duplicated using existing DMRC
clinical health and safety reporting procedures and in ac-
cordance with the principles of good clinical practice
(GCP). In the unlikely event this study is prematurely
terminated for any reason, the MoD research ethics
committee will be informed and provided with the justi-
fication for this action.
Publication policy
We will submit the results of our study for publication
in a suitable journal regardless of the outcomes. The
trial will be reported in accordance with the CONSORT
statement [25]. The chief investigator will take responsi-
bility for producing draft report manuscripts and all co-
investigators will review and approve the study results
prior to submission for publication. Authorship of all
manuscripts and presentations will comply with the
ICMJE “Uniform requirements for Manuscripts Submitted
to biomedical Journals” [87].
Timeline
Ethics approval was obtained from the UK Ministry of
Defence research ethics committee in August 2015.
Recruitment of a study administrator was undertaken in
November 2015. Participant recruitment and data collec-
tion will commence in January 2016. All recruitment
and data collection are expected to be completed by
December 2017.
Discussion
Hip arthroscopy and non-surgical interventions such as
the treatments offered by physiotherapists, are recom-
mended in the management of non-arthritic FAI [1, 9].
However, despite the popularity and acceptance of
residential MDT rehabilitation in the UK military, there
are no studies presenting empirical data on the struc-
ture, process or efficacy of non-arthritic hip pain care.
Given the interest in this model across the wider health-
care sector, there is an immediate need to test the efficacy
of residential rehabilitation practice in a randomised trial
to ensure all future patients receive rehabilitation in the
optimal clinical setting.
This paper presents the protocol for a randomised
controlled trial that will compare the effects of a resi-
dential MDT intervention with conventional outpatient
care on pain and physical function in young non-
arthritic hip pain patients. The study will be the first
RCT to evaluate the structure and process of residential
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versus outpatient treatment options in young active
adults with intra-articular, non-arthritic hip pain. The
study design includes methodological elements to min-
imise the potential for bias including a power calcula-
tion, randomisation and intention-to-treat analysis. The
primary and secondary outcomes are reliable and valid
self-report measures of function and pain, quality of life,
and physical capacity tests including dynamic postural
control, walking and HROM.
Bennell et al. [5, 28] have previously employed a semi-
structured treatment programme similar to the out-patient
intervention in our study. These authors highlight that
whilst this approach restricts individual tailoring of the
programme, it reduces treatment variation thereby ensur-
ing the intervention is accurately reported and replicated.
We chose not to include a ‘no treatment’ control arm as
natural recovery is unlikely to occur in participants report-
ing functional impairments and pain at baseline [28], and
imposing natural recovery could be considered unethical.
There are some potential limitations with the study
design. It is not possible to blind the participants or
supervising therapy staff in clinical trials requiring in-
formed consent and we cannot discount the possibility
of assessor bias. The lack of follow-up beyond 12-weeks
will not capture any longer term benefits of rehabilita-
tion and will restrict our analysis to the period of inter-
vention and home-based programme. Additionally, the
use of a well-defined military population undergoing
residential rehabilitation may limit the generalisability of
our results to other populations and settings. However,
we believe our study will yield results of relevance to
practitioners and young active adults (e.g., sports partici-
pants) undergoing rehabilitation for non-arthritic hip pain.
This study will use high quality methodology in ac-
cordance with the CONSORT statement for randomised
controlled trials [25]. It will respond to the lack of ran-
domised trials directly comparing a residential MDT
intervention with usual out-patient care for non-arthritic
hip pain. The results will add to the evidence-base and
inform clinical practice for the management of intra-
articular hip pain and FAI in young active adults.
Additional file
Additional file 1: MILO Study Intervention Guide. (PDF 2127 kb)
Abbreviations
ADMR: Academic Department of Military Rehabilitation; ANOVA: Analysis of
variance; BMI: Body mass index; CI: Confidence intervals; CONSORT: Consolidation
of standards of reporting trials; DMRC: Defence Medical Rehabilitation Centre;
ERI: Exercise rehabilitation instructor; FAI: Femoroacetabular impingement;
GCP: Good clinical practice; HADS: Hospital anxiety depression scale;
HAGOS: (Copenhagen) Hip and groin outcome score; HROM: Hip range of
motion; ICMJE: International Committee of Medical Journal Editors;
IMO: Independent medical officer; IP: Individual programme; ITT: Intention-to-treat;
MCID: Minimal clinically important difference; MDT: Multidisciplinary team;
MIAC: Multidisciplinary injury assessment clinic; MILO: Military hip rehabilitation
outcome; MOD: Ministry of defence; MODREC: Ministry of Defence Research Ethics
Committee; NAHS: Non-arthritic hip score; NSAID: Non-steroidal anti-inflammatory
drugs; OA: Osteoarthritis; OARSI: Osteoarthritis Research Society International;
OT: Occupational therapist; PCRF: Primary Care Rehabilitation Facility;
PT: Physiotherapist; QOL: Quality of life; RCT: Randomised controlled trial;
RRU: Regional Rehabilitation Unit; SEBT: Star excursion balance test;
SIRBS: Sports injury rehabilitation beliefs survey; UK: United Kingdom;
VAS: Visual analogue scale
Acknowledgements
The authors wish to thank the staff and patients on the Centre for Lower
Limb Rehabilitation at DMRC for their support in delivering this study. Thanks
to the Medical Officers at selected UK military feeder units for identifying
and referring the research participants. Thanks to Richard Dixon, Tony Jones,
Christine Poole and staff at 22 Training Group (HQ Air) Media Graphics
department for producing supporting literature for the study.
Funding
This study is funded by the Arthritis Research UK Centre for Sport, Exercise
and Osteoarthritis (Grant reference 20194).
Availability of data and materials
Not applicable owing to the study type.
Authors’ contributions
All authors were involved in the design of the study. RC, JB, AW and AB
conceived the study, obtained approval from the MOD research ethics
committee and wrote the manuscript. JB secured funding for the study. JB,
AKW and AB will act as supervisors to RC who will conduct the research in
fulfilment of a PhD programme. AW and RC prepared the data analysis plan.
IM, LP and AN developed the rehabilitation and outpatient physiotherapy
intervention protocols. IM will be lead consultant and LP the lead physiotherapist
in the conduct of the study. All authors have read and approved the final
manuscript and provided critical comment. RC will act as study co-ordinator.
Authors’ information
RC is the clinical research manager at DMRC Headley Court and is currently
completing a PhD programme in conjunction with the university of Bath,
UK. JB is head of the Department for Health at the University of Bath, UK.
AW is lecturer in applied statistics on the School of Clinical Sciences at the
University of Bristol, UK. IM is a consultant in rehabilitation and sport and
exercise medicine (SEM) and lead consultant for hip and groin rehabilitation
on the centre for lower limb rehabilitation at DMRC Headley Court, UK. LP is
chair of the UK defence rehabilitation hip and groin best-practice working
group and lead physiotherapist on this study. AN is a consultant in sport and
exercise medicine (SEM) and military clinical director at DMRC Headley Court,
UK. AB is a consultant in rheumatology and rehabilitation (R & R) and head
of research at DMRC Headley Court, UK.
Competing interests
The authors declare they have no competing interests.
Consent for publication
The patient exercise programmes illustrated in the Additional file 1 are
employed across the UK defence rehabilitation setting and all individuals
depicted demonstrating exercise and examination technique have provided
their consent for publication.
Ethics approval and consent to participate
The study has been reviewed and approved by the UK Ministry of Defence
(MOD) research ethics committee (committee study reference protocol 576
dated 01 Nov 2014). Patients participation in the study is purely voluntary
and potential participants will be provided with detailed written information
about the voluntary nature of the study. The right for the participant to
refuse consent without providing reasons and without prejudice will be
emphasised, and volunteers will be free to withdraw from the study at any
time without prejudicing any further treatment. The process of obtaining
written consent will be clearly documented in the investigator site file.
Coppack et al. BMC Musculoskeletal Disorders  (2016) 17:459 Page 14 of 17
Author details
1Academic Department of Military Rehabilitation, Defence Medical
Rehabilitation Centre (DMRC), Epsom, UK. 2Department for Health, University
of Bath, Bath, UK. 3School of Clinical Sciences, University of Bristol, Bristol, UK.
4Centre for Lower Limb Rehabilitation, Defence Medical Rehabilitation Centre
(DMRC), Epsom, UK. 5Leeds Institute of Rheumatic and Musculoskeletal
Medicine, University of Leeds, Leeds, UK.
Received: 13 May 2016 Accepted: 26 October 2016
References
1. Hunt D, Prather H, Harris-Hayes M, Clohisy JC. Clinical outcomes analysis of
conservative and surgical treatment of patients with clinical indications of
prearthritic, intra-articular hip disorders. PM R. 2012;4:479–87.
2. Burnett RS, Della Rocca GJ, Prather H, Curry M, Maloney WJ, Clohisy JC.
Clinical presentation of patients with tears of the acetabular labrum.
J Bone Joint Surg Am. 2006;88:1448–57.
3. Clohisy JC, Kanus ER, Hunt DM, Lesher JM, Harris-Hayes M, Prather H.
Clinical presentation of patients with symptomatic anterior hip
impingement. Clin Orthop Relat Res. 2009;467:638–44.
4. Prather H, Hunt D, Fourine A, Clohisy JC. Early intra-articular hip disease
presenting with posterior pelvic and groin pain. PM R. 2009;1:809–15.
5. Bennell KL, O’Donnell JM, Takla A, Spiers LN, Hunter DJ, Staples M, Hinman RS.
Efficacy of a physiotherapy rehabilitation program for individuals undergoing
arthroscopic management of femoroacetabular impingement-the FAIR
trial: a randomised controlled trial protocol. Musculoskelet Disord.
2014;15(58):1–11.
6. Audeneart EA, Mathieu P, Pattyn C. Three-dimensional assessment of cam
engagement in femoroacetabular impingement. Arthroscopy. 2011;27(2):
167–71.
7. Ganz R, Parvizi J, Beck M, Leunig M, Notzli H, et al. Femoroacetabular
impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res.
2003;30:112–20.
8. Agricola R, Heijboer MP, Bierma-Zeinstra SMA, Verhaar JAN, Weinans H, et al.
Cam impingement causes osteoarthritis of the hip: a nationwide
prospective cohort study (CHECK). Ann Rheum Dis. 2013;72:918–23.
9. Agricola R, Heijboer MP, Roze RH, Reijman M, Bierma-Zeinstra SMA, et al.
Pincer deformity does not lead to osteoarthritis of the hip whereas
acetabular dysplasia does: acetabular coverage and development of
osteoarthritis in a nationwide prospective cohort study (CHECK). Osteoarthr
Cartil. 2013;47:1514–21.
10. Wall H, Fernandez M, Griffin RD, Foster NE. Nonoperative treatment for
femoroacetabular impingement: a systematic review of the literature.
PM R. 2013;5:418–26.
11. Byrd JW. Hip arthroscopy: surgical indications. Arthroscopy. 2006;22:1260–2.
12. Macfarlane RJ, Haddad FS. The diagnosis and management of femoro-
acetabular impingement. Ann R Coll Surg Engl. 2010;92:363–7.
13. Emara K, Samir W, Motasem EH, Ghafer KAE. Conservative treatment for
mild femoroacetabular impingement. J Orthop Surg. 2011;19(1):41–5.
14. Hack K, Di Primio G, Rakhra K, et al. Prevalence of cam-type
femoroacetabular impingement morphology in asymptomatic volunteers.
J Bone Joint Surg Am. 2010;92(14):2436–44.
15. Aprile I, Rizzo RS, Romanini E, De Santis F, Marsan S, Rinaldi G, Padua L.
Group rehabilitation versus individual rehabilitation following knee and hip
replacement: a pilot study with randomised, single-blind, cross-over design.
Eur J Phys Rehabil Med. 2011;47:551–9.
16. Angst F, Verra ML, Lehmann S, et al. Effects of inpatient rehabilitation in hip
and knee osteoarthritis: a naturalistic prospective cohort study with
intraindividual control of effects. Arch Phys Med Rehabil. 2013;94:2139–45.
17. McCuish WJ, Bearne LM. Do inpatient multidisciplinary rehabilitation
programmes improve health status in people with long-term
musculoskeletal conditions? A service evaluation. Musculoskelet Care.
2014;244–250.
18. Kamper SJ, Apeldoorsn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial
rehabilitation for chronic low back pain: Cochrane systematic review and
meta-analysis. BMJ. 2015;350:h444.
19. Momsen AM, Rasmussen JO, Nielsen CV, Iversen MD, Lund H. Multidisciplinary
team care in rehabilitation: an overview of reviews. J Rehabil Med.
2012;44:901–12.
20. Kjeken I, Ingvild B, RØnningen A, Spada C, Mowincel P, et al. A three-week
multidisciplinary in-patient rehabilitation programme had positive long-term
effects in patients with ankylosing spondylitis: randomised controlled trial.
J Rehabil Med. 2013;45:260–7.
21. Stockton KA, Mengersen KA. Effect of multiple physiotherapy sessions on
functional outcomes in the initial postoperative period after primary total
hip replacement: a randomised controlled trial. Arch Phys Med Rehabil.
2009;90:1652–7.
22. Moffett H, Collet JP, Shapiro SH, Paradis G, et al. Effectiveness of intensive
rehabilitation on functional ability and quality of life after first total knee
arthroplasty: a single-blind randomised controlled trial. Arch Phys Med
Rehabil. 2004;85:546–56.
23. Radaelli R, Fleck SJ, Leite T, Leite RD, et al. Dose-response of 1,3, and 5 sets
of resistance exercise on strength, local muscular endurance, and
hypertrophy. J Strength Cond Res. 2015;29(5):1349–58.
24. Carmeli E, Sheklow SL, Colman R. A comparative study of organised class-
based exercise programs versus individual home-based exercise programs
for elderly patients following hip surgery. Disabil Rehabil. 2006;28:997–1005.
25. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines
for reporting parallel group randomised trials. BMJ. 2010;340:697–702.
26. De Roy PG. Helsinki and the declaration of Helsinki. World Med J. 2004;50(1):
9–11.
27. Krauss I, Steinhilber B, Haupt G, Miller R, Martus P, Janssen P. Exercise therapy
in hip osteoarthritis-a randomized controlled trial. Stsch Arztebl Int.
2014;111:592.
28. Bennell KL, Egerton T, Pua YH, Abbott HJ, Sims K, Metcalfe B, McManus F,
Wrigley TV, Forbes A, Harris A, Buchbinder R. Efficacy of a multimodal
physiotherapy treatment program for hip osteoarthritis: a randomised
placebo-controlled trial protocol. BMC Musculoskelet Disord. 2010.
http://www.biomedcentral.com/1471-2474/11/238.
29. Bennell KL, Egerton T, Pua YH, Abbott HJ, Sims K, Buchbinder R. Building the
rationale and structure for a complex physical therapy intervention within
the context of a clinical trial: a multimodal individualized treatment for
patients with hip osteoarthritis. Phys Ther. 2011;91(10):1525–41.
30. Wright AA, Hegedus EJ, Taylor JB, Dischiavi SL, Stubbs AJ. Non-operative
management of femoroacetabular impingement: a prospective, randomized
controlled clinical trial pilot study. J Sci Med Sport. 2016. http://dx.doi.org/
10.1016/j.jsams.2015.11.008.
31. Pisters MF, Veenhof C, Schellevis FG, Twisk JWR, Dekker J, De-Bekker DH.
Exercise adherence improving long-term patient outcome in patients with
osteoarthritis of the hip and/or knee. Arthritis Care Res (Hoboken). 2010;
62(8):1087–94.
32. Wade DT, de Jong BA. Recent advances in rehabilitation. BMJ. 2000;320:
1385–8.
33. Tannast M, Sienbrock KA. Conventional radiographs to assess femoroacetabular
impingement. Instr Course Lect. 2009;58:203–12.
34. Day SJ, Altman DG. Statistics notes: blinding in clinical trials and other
studies. BMJ. 2000;321:504.
35. Roddy E, Zhang W, Doherty M, Arden NK, Barlow J, Birrell F, et al.
Evidence-based recommendations for the role of exercise in the
management of osteoarthritis of the hip or knee – the MOVE consensus.
Rheumatology. 2005;44:67–73.
36. French HP, Cusack T, Brennan A, Caffrey A, Conroy R, Cuddy V, et al.
Exercise and manual physiotherapy arthritis research trial (EMPART) for
osteoarthritis of the hip: a multicenter randomised controlled trial.
Arch Phys Med Rehabil. 2013;94:302–14.
37. Haxby-Abbott J, Robertson MC, McKenzie JE, Baxter D, Theis JC, Campbell
AJ. Exercise therapy, manual therapy, or both, for osteoarthritis of the hip or
knee: a factorial randomised controlled trial protocol. 2009. Retrieved from
biomed Central open Access, http://www.trialsjournal.com/content/10/1/11.
38. Retchford T, Crossley KM, Grimaldi A, Kemp JL, Cowan SM. Can local muscles
augment stability in the hip? A narrative literature review. J Musculoskelet
Neuronal Interact. 2013;13:1–12.
39. Arokoski JP, Kankaanpaa M, Valta T, et al. Back and hip extensor muscle
function during therapeutic exercises. Arch Phys Med Rehabil. 1999;80:842–50.
40. Eneski K, Harris-Hayes M, White DM, Cibulka MT. Non-arthritic hip pain: clinical
practice guidelines linked to the international classification of functioning,
disability, and health from the orthopaedic section of the American Physical
Therapy Association. J Orthop Sports Phys Ther. 2014;44(6):A1–32.
41. Giphart JE, Stull JD, Laprade RF, Wahoff MS, Phillipon MJ. Recruitment and
activity of the pectineus and piriformis muscles during hip rehabilitation
Coppack et al. BMC Musculoskeletal Disorders  (2016) 17:459 Page 15 of 17
exercises: an electromyography study. Am J Sports Med.
2012;40(7):1654–63.
42. Reiman MP, Lorenz DS. Integration of strength and conditioning principles
into a rehabilitation program. Int J Sports Ther. 2011;6(3):241–53.
43. Linton S, Hellsing A, Bergstrom G. Exercise for workers with musculoskeletal pain:
does enhancing compliance decrease pain? J Occup Health. 1996;6:177–89.
44. Wang SY, Olson-Kellogg B, Shamiliyan TA, Choi JY, Ramakrishnan R, et al.
Physical therapy interventions for knee pain secondary to osteoarthritis: a
systematic review. Ann Intern Med. 2012;157:632–44.
45. Tijssen M, van Cingel REH, Staal JB, Teerenstra S, de Visser E, et al.
Physical therapy aimed at self-management versus usual care physical
therapy after hip arthroscopy for femoroacetabular impingement: study
protocol for a randomized controlled trial. Trials. 2016;17:91. doi:10.1186/
s13063-016-1222-7.
46. Bennell KL, Egerton TE, Martin J, Haxby-Abbott J, Metcalf B, McManus F,
Sims K, et al. Effect of physical therapy on pain and function in patients
with hip osteoarthritis: a randomized clinical trial. JAMA. 2014;311(19):1987–97.
doi:10.1001/jama.2014.4591.
47. Fernandes L, Storheim K, Nordsletten L, Risberg MA. Development of a
therapeutic exercise program for patients with osteoarthritis of the hip.
Phys Ther. 2010;90(4):592–601.
48. Ageberg E, Nilsdotter A, Kosek E, Roos EM. Effects of neuromuscular training
(NEMEX-TJR) on patient-reported outcomes and physical function in severe
primary hip or knee osteoarthritis: a controlled before-and-after study. 2013.
Retrieved from biomed Central open access, http://www.biomedcentral.
com/1471-2474/14/232.
49. Phillipon MJ, Decker MJ, Giphart JE, et al. Rehabilitation exercise progression
for the gluteus medius muscle with consideration for illiopsoas tendinitis.
Am J Sports Med. 2011;39(8):1777–85.
50. Øistad BE, Østeras N, Frobell R, Grotle M, Brøgger H, Risberg MA. Efficacy of
strength and aerobic exercise on patient-reported outcomes and structural
changes in patients with knee osteoarthritis: study protocol for a
randomized controlled trial. 2013. Retrieved from biomed Central open
access http://www.biomedcentral.com/1471-2474/14/266.
51. Deyle GD, Henderson NE, Matekel RL, Ryder MG, Garber MB, Allison SC.
Effectiveness of manual physical therapy and exercise in osteoarthritis of
the knee. Ann Intern Med. 2000;132(3):173–81.
52. Bezalel T, Carmeli E, Katz-Leurer M. The effect of a group education
programme on pain and function through knowledge acquisition and
home-based exercise among patients with knee osteoarthritis: a parallel
randomised single-blind clinical trial. Physiotherapy. 2010;96:137–43.
53. Hinman RS, Dobson F, Takla A, O’Donnell J, Bennell KL. Which is the
most useful patient-reported outcome in femoroacetabular impingement?
Test-retest reliability of six questionnaires. J Sports Med.
2004;48:458–63.
54. Coppack RJ, Bilzon JL, Wills AK, McCurdie IM, et al. Physical and functional
outcomes following multidisciplinary residential rehabilitation for prearthritic
hip pain among young active UK military personnel. BMJ Open Sport Exerc Med.
2016;2, e000107. doi:10.1136/bmjsem-2015-000107.
55. Pham T, Heijde DV, Lasser M, Altman RD, Anderson JJ, Bellamy N, et al.
Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set
of responder criteria. J Rheumatol. 2003;30(7):1648–54.
56. Thorborg K, Hölmich P, Christensen R, Petersen J, Roos EM. The Copenhagen
Hip and Groin Outcome Score (HAGOS): development and validation
according to the COSMIN checklist. Br J Sports Med. 2011;45:478–91.
57. Harris-Hayes M, McDonough CM, Leunig M, Lee CB, Callaghan JJ, Roos EM.
Clinical outcomes assessment in clinical trials to assess treatment of
femoroacetabular impingement: use of patient reported outcome measures.
J Am Acad Orthop Surg. 2013;21(01):S39–46.
58. Thorborg K, Tijssen M, Habets B, Bartels EM, Roos EM, Kemp J, Crossley
KM, Hölmich P. Patient-reported outcome (PRO) questionnaires for young-
aged to middle-aged adults with hip and groin disability:a systematic
review of the clinimetric evidence. Br J Sports Med. 2015;0:1–11. doi:10.
1136/bjsports-2014-094224.
59. Christensen CP, Althausen PL, Mittlemen MA, et al. The nonarthritic hip
score: reliable and validated. Clin Orthop Relat Res. 2003;75–83.
60. Mohtadi NGH, Griffin DR, Pedersen ME, Chan D, Safran MR, Parsons N,
Sekiya JK, et al. The development and validation of a self-administered
quality-of-life outcome measure for young, active patients with
symptomatic hip disease: the international hip outcome tool (iHOT-33).
J Arthrosc Relat Surg. 2012;28(5):595–610.
61. Collins SL, Moore RA, McQuay HU. The visual analogue pain intensity scale:
What is moderate pain in millimetres? Pain. 1997;72:95–7.
62. Fransen M, Edmonds J. Reliability and validity of the EuroQol in patients
with osteoarthritis of the knee. Rheumotology. 1999;38:807–13.
63. Parsons N, Griffin XL, Achten J, Costa ML. Outcome assessment after hip
fracture: is EQ-5D the answer? Bone Joint Res. 2014;3:69–75.
64. Schencking M, Otto A, Deutsch T, Sandholzer H. A comparison of Kneipp
hydrotherapy with conventional physiotherapy in the treatment of
osteoarthritis of the hip or knee: protocol of a prospective randomised
controlled clinical trial. BMC Musculoskelet Disord. 2009. http://www.
biomedcentral.com/1471-2474/10/104.
65. Barker KL, Newman MA, Hughes CS, Pandit H, Kiran A, Murray DW. Recovery
of function following hip resurfacing arthroplasty: a randomised controlled
trial comparing an accelerated versus standard physiotherapy. Clin Rehabil.
2013;27(9):771–84.
66. Skou ST, Odgaard A, Rasmussen JO, Roos EM. Group education and
exercise is feasible in knee and hip osteoarthritis. Dan Med J.
2012;59(12):1–5.
67. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital
anxiety and depression scale. An updated literature review. J Psychosom
Res. 2002;52(2):925–34.
68. Rosemann T, Kuehlein T, Laux G, Szecsenyl J. Factors associated with
physical activity of patients with osteoarthritis of the lower limbs. J Eval Clin
Pract. 2008;14(2):288.
69. Stratford PW, Kennedy DM. Performance measures were necessary to obtain a
complete picture of osteoarthritic patients. J Clin Epidemiol. 2006;59(2):160–7.
70. Balke B. A simple field test for the assessment of physical fitness. Rep Civ
Aeromed Res Inst US. 1963;53:1607–8.
71. Dobson F, Hinman RS, Hall M, Terwee CB, Roos EM, Bennell KL.
Measurement properties of performance-based measures to assess physical
function in hip and knee osteoarthritis: a systematic review. Osteoarthr
Cartil. 2012;20:1548–62.
72. Wright AA, Cook CE, Baxter GD, Dockerty JD, Abbott JH. A comparison of 3
methodological approaches to defining major clinically important
improvement of 4 performance measures in patients with hip osteoarthritis.
J Orthop Sports Phys Ther. 2011;41:319–27.
73. Kiss R. Effect of the degree of hip osteoarthritis on equilibrium ability after
sudden changes in direction. J Electromyogr Kinesiol. 2010;20:1052–7.
74. Hertel J, Braham RA, Hale SA, Olmsted-Kramer LC. Simplifying the star
excursion balance test: analyses of subjects with and without chronic ankle
instability. J Orthop Sports Phys Ther. 2006;36:131–7.
75. Hegedus EJ, Stern B, Reiman MP, Tarara D, Wright AA. A suggested model
for physical examination and conservative treatment of athletic pubalgia.
Physical Therapy in Sport. 2013;14:3–16.
76. Filipa A, Byrnes R, Paterno MV, Myer GD, Hewett TE. Neuromuscular training
improves performance on the star excursion balance test in young female
athletes. J Orthop Sports Phys Ther. 2010;40(9):551–8.
77. Holm I, Bolstad B, Lutken T, Ervik A, Rokkum M, Steen H. Reliability of
goniometric measurements and visual estimates of hip ROM in patients
with osteoarthritis. Physiother Res Int. 2000;5(4):241–8.
78. Thorborg K, Petersen J, Magnusson P, Hömlich P. Clinical assessment of hip
strength using a hand-held dynamometer is reliable. Scand J Med Sci
Sports. 2010;20:493–501.
79. Thorborg K, Bandholm T, Hömlich P. Hip and knee strength assessments
using a hand-held dynamometer with external belt-fixation are inter-tester
reliable. Knee Surg Sports Traumatol Arthrosc. 2013;21:550–5.
80. Bloom N, Cornbleet SL. Hip rotator strength in healthy young adults
measured in hip flexion and extension by using a hand-held dynamometer.
PM R. 2014;6:1137–42.
81. Ieiri A, Tushima E, Ishida K, Inoue M, Kanno T, Takeshi T. Reliability of
measurements of hip abduction strength obtained with a hand-held
dynamometer. Physiother Theory Pract. 2015;31(2):146–52.
82. Brekke M, Hjortdahl P, Kvien TK. Changes in self-efficacy and health status
over 5-years: a longitudinal observational study of 306 patients with
rheumatoid arthritis. Arthritis Rheum. 2003;49:342–8.
83. Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA,
et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern
Med. 2000;133:726–37.
84. Taylor AH, May S. Threat and coping appraisal as determinants of
compliance with sports injury rehabilitation: an application of protection
motivation theory. J Sports Sci. 1996;14:471–82.
Coppack et al. BMC Musculoskeletal Disorders  (2016) 17:459 Page 16 of 17
85. Levy AR, Polman RCJ, Clough PJ, Marchant DC, Earle K. Mental toughness as
a determinant of beliefs, pain, and adherence in sport injury rehabilitation.
J Sport Rehabil. 2006;15:246–54.
86. Weigl M, Angst F, Stucki G, Lehmann S, Aeschlimann A. Inpatient
rehabilitation for hip or knee osteoarthritis: 2 year follow up study.
Ann Rheum Dis. 2003;63:360–8.
87. International Committee of Medical Journal Editors. Uniform Requirements
for Manuscripts Submitted to Biomedical Journals: Writing and Editing for
Biomedical Publication. Philadelphia: International Committee of Medical
Journal Editors; 2007.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Coppack et al. BMC Musculoskeletal Disorders  (2016) 17:459 Page 17 of 17
